. Author manuscript; available in PMC: 2018 Jan 15.

Published in final edited form as: J Affect Disord. 2016 Oct 26;208:560–566. doi: 10.1016/j.jad.2016.10.026

Table 2.

Day 1 Symptom Severity Correlation with Antidepressant Response to Ketamine at Two Weeks (MADRS Percent Change from Baseline)

Variable	r	r²	p	p_adjusted^*
Reported Sadness	−.34	.116	.001	.01
Difficulty Concentrating	−.32	.102	.002	.02
Inability to Feel	−.31	.096	.002	.02
Apparent Sadness	−.30	.090	.003	.03
Lassitude	−.26	.068	.012	.12
Pessimistic Thoughts	−.23	.053	.024	.24
Inner Tension	−.23	.053	.029	.29
Reduced Appetite	−.23	.053	.026	.26
Suicidal Thoughts	−.22	.048	.037	.37
Reduced Sleep	−.08	.006	.48	1.00

Bonferroni-corrected for multiple comparisons; bolded variables were significant.

Abbreviations: MADRS: Montgomery Åsberg Depression Rating Scale